- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00284492
Acupuncture for Hot Flushes in Menopause (ACUFLASH)
Effectiveness of Acupuncture-care for Treatment of Hot Flushes Among Postmenopausal Women
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study objective is to determine whether Traditional Chinese Medicine (TCM) acupuncture-care together with self-care is more effective than self-care alone, to relieve climacteric complaints among women who seek alternatives to hormonal replacement therapy (HRT). Study design is a pragmatic randomised controlled trial with two parallel arms. Study participants are postmenopausal women who document a mean value of 7 flushes/24 hours and who are not using HRT or other prescribed medication that may influence climacteric complaints. The treatment group will receive 10 sessions of TCM acupuncture-care and self-care; the control group will engage in self-care only.
The duration of intervention period is 12 weeks with evaluations at baseline, 4, 8, 12 weeks, and follow up at 6 and 12 months after baseline. Primary endpoint is change in daily hot flush frequency in the two groups from baseline to 12 weeks; secondary endpoint is health related quality of life. N in each treatment group: 143 (286 altogether).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tromsø, Norway, No-9038
- Clinical Research Center, University Hospital of North Norway
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Postmenopausal women (at least one year past the last menstrual period) who are willing to receive acupuncture and who during two weeks of self-completed diaries10 document a mean value of 7 flushes/24 hours or more (or 50 flushes or more over a period of seven consecutive days), will be randomized after a baseline evaluation.
- Current users prescribed medications that influence hot flush rate (e. g. HRT, SSRI's) can be included after a washout period. The washout-periods are eight weeks for SSRI's and systemic (including transdermal) HRT and four weeks for local estradiol preparations
Exclusion Criteria:
- Surgical menopause
- History of cancer within the past five years
- Use of anticoagulant drugs
- Heart valve disease
- Poorly controlled hypertension
- Hypothyroidism
- Hyperthyroidism or diabetes mellitus
- Organ transplant
- Mental disease
- Overt drug or alcohol dependency
- Inability to complete study forms
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Lifestyle advice
|
Lifestyle advice on diet, physical activity
|
|
Experimental: Lifestyle advice and acupuncture therapy
|
10 acupuncture sessions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Frequency of hot flushes
Time Frame: 12 weeks
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Health related quality of life (Women's Health Questionnaire)
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sameline Grimsgaard, MD, MPH, PhD, University Hospital of North Norway. No-9038 Tromsø, Norway
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P REK NORD 102/2005
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hot Flashes
-
University of California, San FranciscoCompleted
-
Tanabe Pharma America, Inc.CompletedMenopause Hot FlashesUnited States
-
AmgenCompleted
-
University of California, San FranciscoCompleted
-
Rebecca ThurstonAstellas Pharma Global Development, Inc.Not yet recruiting
-
Alison Huang, MDNational Institute on Aging (NIA)Completed
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedTreatment of Menopausal Hot FlashesUnited States
-
Nutraceuticals Research InstituteNot yet recruitingMenopausal Women | Menopausal Hot FlashesUnited States
-
University of Colorado, DenverRecruitingMenopause | Menopause Related Conditions | Cardiovascular | Menopause Hot FlashesUnited States
-
Donesta BioscienceSynteractHCRCompleted
Clinical Trials on Self Care
-
University of LiegeUnknownComparison of Treatment for Chronic Non-malignant and Malignant PainBelgium
-
University of LiegeCompletedComparison of Different Treatment for Chronic Pain
-
Universität Duisburg-EssenDeutsche Morbus Crohn / Colitis ulcerosa Vereinigung DCCVCompleted
-
VA Office of Research and DevelopmentCompletedObstructive Sleep ApneaUnited States
-
Emory UniversityNational Institute of Nursing Research (NINR); Atlanta VA Medical Center; Atlanta...CompletedHeart Failure | Diabetes MellitusUnited States
-
University of LiegeJules Bordet Institute; King Baudouin Foundation; Fonds National de la Recherche...CompletedNon-Metastatic NeoplasmBelgium
-
University of LiegeFondation BenoitWithdrawnNon-Metastatic NeoplasmBelgium
-
University of LiegeFondation BenoitUnknown
-
University of LiegeFree University of BrusselsCompleted